Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 11 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 6936720

    Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 30, 2005 · Expires Aug 25, 2025

    expired
  2. US 6930186

    Process for the preparation of paroxetine substantially free of alkoxy impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 16, 2005 · Expires Aug 11, 2025

    expired
  3. US 6909004

    Method for the purification of lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 21, 2005 · Expires Jun 16, 2025

    expired
  4. US 6881420

    Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 19, 2005 · Expires Apr 14, 2025

    expired
  5. US 6861553

    Process for preparing nateglinide and intermediates thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 1, 2005 · Expires Feb 24, 2025

    expired
  6. US 6861426

    Crystal forms of lamotrigine and processes for their preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 1, 2005 · Expires Feb 24, 2025

    expired
  7. US 6858652

    Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 22, 2005 · Expires Feb 17, 2025

    expired
  8. US 6849736

    Crystalline forms of valacyclovir hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  9. US 6849737

    Synthesis and purification of valacyclovir

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  10. US 6849120

    Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  11. US 6806373

    Process for preparing leflunomide form I

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 19, 2004 · Expires Oct 14, 2024

    expired
  12. US 6800759

    Racemization and enantiomer separation of clopidogrel

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 5, 2004 · Expires Sep 30, 2024

    expired
  13. US 6774230

    Methods for the preparation of mirtazapine intermediates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 10, 2004 · Expires Aug 5, 2024

    expired
  14. US 6764997

    Stabilized azithromycin compositions

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 20, 2004 · Expires Jul 15, 2024

    expired
  15. US 6750341

    Preparation of risperidone

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 15, 2004 · Expires Jun 10, 2024

    expired
  16. US 6737411

    Racemization and enantiomer separation of clopidogrel

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 18, 2004 · Expires May 13, 2024

    expired
  17. US 6723855

    Method for synthesizing leflunomide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 20, 2004 · Expires Apr 15, 2024

    expired
  18. US 6710184

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 23, 2004 · Expires Mar 18, 2024

    expired
  19. US 6703424

    Dispersible compositions containing L-DOPA ethyl ester

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2004 · Expires Mar 4, 2024

    expired
  20. US 6699997

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 2, 2004 · Expires Feb 26, 2024

    expired
  21. US 6696600

    L-DOPA ethyl ester salts and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  22. US 6696601

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  23. US 6689384

    Stable pergolide mesylate and process for making same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  24. US 6670478

    Process for preparing torsemide intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired